Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev Assoc Med Bras (1992) ; 66(4): 407-413, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32578771

RESUMO

OBJECTIVE: Analyzing the association between ABI and the main risk factors for coronary artery disease in coronary patients. METHODS: Were selected 156 adult patients from a hospital in Maceió, Alagoas. Were evaluated with risk factors age, obesity, hypertension, diabetes mellitus, smoking, and dyslipidemia. PAOD screening was performed by the ankle-brachial index (ABI). The Mann-Whitney, chi-square, and Fisher's exact tests were used. Confidence Interval of 95% and a significance of 5%. RESULTS: 67.3% (n=105) males, 52.6% (n=82) elderly, 23.1% (n = 34) obese, 72.4% 6% (n=113) hypertensive, 34.6% (n=54) diabetics, 53.2% (n=83) smokers, 34.6% (n=54) dyslipidemic and 70.5% (n=110) with a family history of CAD. 16.7% (n=26) of the individuals presented PAOD. Three factors were associated with PAOD: age group ≥ 60 years (OR:3.656; p=0.005), diabetes mellitus (OR:2.625; p=0.024) and hypertension (OR:5.528; p=0.008). No significant difference was observed in the variables smoking, dyslipidemia, family history of CAD, and obesity. CONCLUSION: The independent risk factors for PAOD were age, diabetes mellitus, and systemic arterial hypertension.


Assuntos
Índice Tornozelo-Braço , Doença da Artéria Coronariana , Adulto , Idoso , Diabetes Mellitus , Humanos , Hipertensão , Masculino , Fatores de Risco
2.
Rev Assoc Med Bras (1992) ; 66(4): 407-413, 2020. tab, graf
Artigo em Inglês | Sec. Est. Saúde SP, LILACS | ID: biblio-1136234

RESUMO

SUMMARY OBJECTIVE Analyzing the association between ABI and the main risk factors for coronary artery disease in coronary patients. METHODS Were selected 156 adult patients from a hospital in Maceió, Alagoas. Were evaluated with risk factors age, obesity, hypertension, diabetes mellitus, smoking, and dyslipidemia. PAOD screening was performed by the ankle-brachial index (ABI). The Mann-Whitney, chi-square, and Fisher's exact tests were used. Confidence Interval of 95% and a significance of 5%. RESULTS 67.3% (n=105) males, 52.6% (n=82) elderly, 23.1% (n = 34) obese, 72.4% 6% (n=113) hypertensive, 34.6% (n=54) diabetics, 53.2% (n=83) smokers, 34.6% (n=54) dyslipidemic and 70.5% (n=110) with a family history of CAD. 16.7% (n=26) of the individuals presented PAOD. Three factors were associated with PAOD: age group ≥ 60 years (OR:3.656; p=0.005), diabetes mellitus (OR:2.625; p=0.024) and hypertension (OR:5.528; p=0.008). No significant difference was observed in the variables smoking, dyslipidemia, family history of CAD, and obesity. CONCLUSION The independent risk factors for PAOD were age, diabetes mellitus, and systemic arterial hypertension.


RESUMO OBJETIVO Analisar a associação entre o ITB e os principais fatores de risco para doença arterial coronariana em indivíduos coronariopatas. MÉTODOS Foram selecionados 156 pacientes adultos de um hospital de Maceió, Alagoas. Foram avaliados como fatores de risco idade, obesidade, hipertensão, diabetes mellitus, tabagismo e dislipidemia. A triagem da DAOP foi realizada pelo índice tornozelo-braquial (ITB). Foram utilizados os testes de Mann-Whitney, qui-quadrado e exato de Fisher. Intervalo de Confiança de 95% e significância de 5%. RESULTADOS 67,3% (n=105) do sexo masculino, 52,6% (n=82) idosos, 23,1% (n=34) obesos, 72,4% (n=113) hipertensos, 34,6% (n=54) diabéticos, 53,2% (n=83) tabagistas, 34,6% (n=54) dislipidêmicos e 70,5% (n=110) com história familiar de DAC; 16,7% (n=26) dos indivíduos apresentaram DAOP. Três fatores foram associados à DAOP: faixa etária ≥60 anos (OR:3,656; p=0,005), diabetes mellitus (OR:2,625; p=0,024) e (OR:5,528; p=0,008). Não foi observada diferença significativa nas variáveis tabagismo, dislipidemia, história familiar de DAC e obesidade. CONCLUSÃO Os fatores de risco independentes para DAOP foram idade, diabetes mellitus e hipertensão arterial sistêmica.


Assuntos
Humanos , Masculino , Adulto , Idoso , Doença da Artéria Coronariana , Índice Tornozelo-Braço , Fatores de Risco , Diabetes Mellitus , Hipertensão
3.
Metab Brain Dis ; 30(1): 93-8, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25005004

RESUMO

Two sources of medium-chain triglycerides--triheptanoin with anaplerotic properties and coconut oil with antioxidant features--have emerged as promising therapeutic options for the management of pharmacoresistant epilepsy. We investigated the effects of ketogenic diets (KDs) containing coconut oil, triheptanoin, or soybean oil on pilocarpine-induced status epilepticus (SE) in rats. Twenty-four adult male Wistar rats were divided into 4 groups and fed a control diet (7% lipids) or a KD containing soybean oil, coconut oil, or triheptanoin (69.8% lipids). The ketogenic and control diets had a lipid:carbohydrate + protein ratio of 1:11.8 and 3.5:1, respectively. SE was induced in all rats 20 days after initiation of the dietary treatment, through the administration of pilocarpine (340 mg/kg; i.p.). The latency, frequency, duration, and severity of seizures before and during SE were observed with a camcorder. SE was aborted after 3 h with the application of diazepam (5 mg/kg; i.p.). The rats in the triheptanoin-based KD group needed to undergo a higher number of seizures to develop SE, as compared to the control group (P < 0.05). Total weight gain, intake, energy intake, and feed efficiency coefficient, prior to induction of SE, differed between groups (P < 0.05), where the triheptanoin-based KD group showed less weight gain than all other groups, less energy intake than the Control group and intermediate values of feed efficiency coefficient between Control and other KDs groups. Triheptanoin-based KD may have a neuroprotective effect on the establishment of SE in Wistar rats.


Assuntos
Dieta Cetogênica , Gorduras na Dieta/uso terapêutico , Estado Epiléptico/dietoterapia , Animais , Óleo de Coco , Convulsivantes/toxicidade , Ingestão de Energia/efeitos dos fármacos , Masculino , Fármacos Neuroprotetores/uso terapêutico , Pilocarpina/toxicidade , Óleos de Plantas/uso terapêutico , Ratos , Ratos Wistar , Convulsões/induzido quimicamente , Convulsões/prevenção & controle , Estado Epiléptico/induzido quimicamente , Triglicerídeos/uso terapêutico , Aumento de Peso/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...